Tempest Therapeutics Inc. logo

Tempest Therapeutics Inc. (TPST)

Market Open
12 Jun, 13:32
NASDAQ (CM) NASDAQ (CM)
$
1. 28
+0.03
+2.4%
$
5.77M Market Cap
- P/E Ratio
- Div Yield
689 Volume
-1.41 Eps
$ 1.25
Previous Close
Investors:
Add Transaction
Day Range
1.26 1.33
Year Range
1.23 12.23
Want to track TPST and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Tempest Therapeutics Inc. (TPST) Statistics

Valuation metrics

Market Cap 5.77M
Enterprise value 11.69M
Trailing P/E (ttm) -0.32
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) -
Price/Book (mrq) 16.89
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.27

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 117.1K
Average volume (90 days) 199.53K

Price summary

52-Week low 1.23
52-Week high 12.23
Beta -
50-Day moving average 1.79
200-Day moving average 2.43

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:13
Last split Date 9 Apr 2025

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -4.01%
Return on equity -7.3%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.94
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.17
Total debt (mrq) -
Total Debt/Equity (mrq) 9.55
Current ratio (mrq) 0.74%
Book value per share (mrq) 0.08

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -